Thuermel Klaus, Einspieler Ingo, Wolfram Sabine, Moog Philipp, Meier Reinhard, Schwaiger Markus, Heemann Uwe
Department of Nephrology and Rheumatology, Klinikum rechts der Isar, Technical University of Munich, Germany.
Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Germany.
Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):146-154. Epub 2016 Dec 14.
The aim of this study was to evaluate the value of fully integrated [18F]-FDG PET/MRI in the assessment of retroperitoneal fibrosis with regard to disease activity, extent and vascular involvement compared to clinical and laboratory parameters.
Seventeen [18F]-FDG PET/MRI examinations were performed in fourteen patients. Qualitative (visual 4-point scale) and quantitative PET parameters (maximum standardised uptake value, SUVmax; target-background ratio, TBR) as well as RF thickness and volume were correlated to clinical and inflammatory parameters and compared between therapy-naïve patients and patients under immunosuppression. Evidence for associated large-vessel vasculitis was examined. Magnetic resonance angiography (MRA) was performed to detect aneurysms or stenoses.
Clinical parameters, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) only incompletely displayed inflammatory activity and did not correlate with PET/MRI parameters. In 29% (4/17) resp. 50% (8/16) of PET/MRI examinations active disease was detected although CRP resp. ESR were in the normal range. SUVmax, TBR and volume of the retroperitoneal mass differed significantly between therapy-naïve patients and patients under therapy (SUVmax p=0.004, TBR p=0.015, volume p=0.015), whereas thickness of the retroperitoneal mass did not (p=0.406). Large-vessel vasculitis was detected in 21% (3/14) and aortic aneurysms in 14% (2/14) of patients. Vasculitis occurred apart from the site of RF in two patients.
Whole body hybrid [18F]-FDG-PET/MRI is superior to clinical and inflammatory parameters in disease activity assessment of RF. There may be substantial disease activity despite inflammatory parameters in the normal range. Associated large-vessel vasculitis and aneurysms may occur apart from the site of RF.
本研究旨在评估全集成[18F]-FDG PET/MRI在评估腹膜后纤维化的疾病活动度、范围及血管受累情况方面的价值,并与临床和实验室参数进行比较。
对14例患者进行了17次[18F]-FDG PET/MRI检查。将定性(视觉4分制)和定量PET参数(最大标准化摄取值,SUVmax;靶本比,TBR)以及腹膜后纤维化厚度和体积与临床和炎症参数进行关联,并在初治患者和免疫抑制治疗患者之间进行比较。检查是否存在相关的大血管血管炎证据。进行磁共振血管造影(MRA)以检测动脉瘤或狭窄。
临床参数、C反应蛋白(CRP)和红细胞沉降率(ESR)仅不完全显示炎症活动,且与PET/MRI参数无相关性。在29%(4/17)和50%(8/16)的PET/MRI检查中,尽管CRP和ESR在正常范围内,但仍检测到活动性疾病。初治患者和接受治疗患者的腹膜后肿块SUVmax、TBR和体积有显著差异(SUVmax p = 0.004,TBR p = 0.015,体积p = 0.015),而腹膜后肿块厚度无差异(p = 0.406)。21%(3/14)的患者检测到有大血管血管炎,14%(2/14)的患者检测到有主动脉瘤。两名患者的血管炎发生在腹膜后纤维化部位以外。
全身[18F]-FDG-PET/MRI在腹膜后纤维化疾病活动度评估方面优于临床和炎症参数。尽管炎症参数在正常范围内,但仍可能存在显著的疾病活动。相关的大血管血管炎和动脉瘤可能发生在腹膜后纤维化部位以外。